Invention Grant
- Patent Title: Deuterium-enriched pioglitazone
-
Application No.: US15917983Application Date: 2018-03-12
-
Publication No.: US10576071B2Publication Date: 2020-03-03
- Inventor: Anthony W. Czarnik
- Applicant: Poxel SA
- Applicant Address: FR Lyons
- Assignee: Poxel SA
- Current Assignee: Poxel SA
- Current Assignee Address: FR Lyons
- Agency: Goodwin Procter LLP
- Main IPC: A61K31/4436
- IPC: A61K31/4436 ; A61K31/4439 ; C07D417/12
Abstract:
The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
Public/Granted literature
- US20190008842A1 DEUTERIUM-ENRICHED PIOGLITAZONE Public/Granted day:2019-01-10
Information query
IPC分类:
